Intercept Pharmaceuticals Inc


Market Cap$0

Compare Intercept Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Intercept Pharmaceuticals IncIntercept Pharmaceuticals Inc00%-86%3.23.1
marketMarket Avg49.51.28%13%6.20.1
HealthcareHealthcare Avg31.91.26%18%7.50.9

Current Fair Value

14% upside

Undervalued by 14% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$-98,858,000.00
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.48
Outstanding Shares41,825,966
Avg 30 Day Volume0


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales3.17
Price to Book Ratio19.0
Enterprise Value to Revenue-0.34
Enterprise Value to EBIT1.38
Enterprise Value to Net Income1
Total Debt to Enterprise-2.26
Debt to Equity3.12

Revenue Sources

No data

ESG Score

No data

About Intercept Pharmaceuticals Inc